It is now widely established that cancer and aging are intrinsically linked. People over the age of 65 make up 60 percent of new cancer diagnoses and 70 percent of cancer deaths. As advances in medicine and healthcare maximize human life expectancy and the elderly population continues to grow, cancer rates are predicted to increase accordingly.
CD BioSciences offers preclinical contract research services dedicated to advancing the field of aging-related cancer research and drug development. With years of experience in the industry, our team of highly proficient biological scientists and experts is committed to providing comprehensive and reliable services to our clients.